Bella Vi Insane Amp’d And Bella Vi Amp’d Up: Public Notification - Undeclared Ingredients
Audience: Consumer, Health Professional
ISSUE: FDA is advising consumers not to purchase or use Bella Vi Insane Amp’d or Bella Vi Amp’d Up. FDA laboratory analyses confirmed that Bella Vi Insane Amp’d and Bella Vi Amp’d Up contain sibutramine. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. These products pose a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and can present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. These products can also interact in life-threatening ways with other medications a consumer may be taking. Laboratory analyses also confirmed that Bella Vi Insane Amp’d and Bella Vi Amp’d Up contain phenolphthalein. Phenolphthalein was an ingredient in some over-the-counter (OTC) laxative products until 1999 when FDA reclassified the ingredient as “not generally recognized as safe and effective.”
BACKGROUND: Bella Vi Insane Amp’d” and “Bella Vi Amp’d are promoted for weight loss and sold on various websites, including www.pureedgenutrition.com and www.newedgenutrition.com, as well as in retail stores.
RECOMMENDATION: Consumers should stop using these products immediately and throw them away. Consumers who have experienced any negative side effects should consult a health care professional as soon as possible.
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
- Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
- Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178